dc.contributor.author | Cannata Andía, Jorge Benito | |
dc.contributor.author | Díaz-Sottolano, A. | |
dc.contributor.author | Fernández, P. | |
dc.date.accessioned | 2022-09-06T07:29:36Z | |
dc.date.available | 2022-09-06T07:29:36Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | BMC Medicine, 20(1) (2022); doi:10.1186/s12916-022-02290-8 | |
dc.identifier.issn | 1741-7015 | |
dc.identifier.uri | http://hdl.handle.net/10651/64716 | |
dc.description.sponsorship | The groups involved in the study received research support from Fondo Europeo de Desarrollo Regional (FEDER), Plan de Ciencia, Tecnología e Innovación 2013–2017 y 2018–2022 del Principado de Asturias (GRUPIN 14‑028, IDI‑2018‑000‑152, IDI/2021/000080). Red Cooperativa en Salud REDinREN y RICORS2040 del Instituto de Salud Carlos III (RD12/0021/1023; RD16/0009/0017;RD21/0005/0019). Instituto de Salud Carlos III (ISCIII)‑Fondo de Investigación Sanitaria: PI17/00715, PI17/00384, PI17/02181, PI19/00532, PI20/00633, PI20/00753. Ayuda para la formación de Profesorado Universitario (FPU). Programa de Ayudas “Severo Ochoa” para la Formación en investigación y Docencia del Principado de Asturias, convocatoria 2019. | |
dc.description.statementofresponsibility | Cannata-Andía JB, Díaz-Sottolano A, Fernández P, Palomo-Antequera C, Herrero-Puente P, Mouzo R, Carrillo-López N, Panizo S, Ibañez GH, Cusumano CA, Ballarino C, Sánchez-Polo V, Pefaur-Penna J, Maderuelo-Riesco I, Calviño-Varela J, Gómez MD, Gómez-Alonso C, Cunningham J, Naves-Díaz M, Douthat W, Fernández-Martín JL; COVID-VIT-D trial collaborators | |
dc.language.iso | eng | |
dc.relation.ispartof | Bmc medicine | |
dc.rights | © 2022 Los autores | |
dc.rights | CC Reconocimiento 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Scopus | |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124775348&doi=10.1186%2fs12916-022-02290-8&partnerID=40&md5=d101c7309e943b3141f4c7b56f4f66f0 | |
dc.title | A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial | |
dc.type | journal article | |
dc.identifier.doi | 10.1186/s12916-022-02290-8 | |
dc.relation.projectID | GRUPIN 14‑028 | |
dc.relation.projectID | IDI‑2018‑000‑152 | |
dc.relation.projectID | IDI/2021/000080 | |
dc.relation.projectID | ISCIII/RD12/0021/1023 | |
dc.relation.projectID | ISCIII/RD16/0009/0017 | |
dc.relation.projectID | ISCIII/RD21/0005/0019 | |
dc.relation.projectID | ISCIII/FIS/PI17/00715 | |
dc.relation.projectID | ISCIII/FIS/PI17/00384 | |
dc.relation.projectID | ISCIII/FIS/PI17/02181 | |
dc.relation.projectID | ISCIII/FIS/PI19/00532 | |
dc.relation.projectID | ISCIII/FIS/PI20/00633 | |
dc.relation.projectID | ISCIII/FIS/PI20/00753 | |
dc.relation.publisherversion | http://dx.doi.org/10.1186/s12916-022-02290-8 | |
dc.rights.accessRights | open access | |
dc.type.hasVersion | VoR | |